Fig. 3
Blood primaquine levels among subjects with normal and reduced CYP2D6 activity phenotype, reference and alternate MAOA and UGT2B7 genotypes. (A) CYP2D6 phenotypes; (B) MAOA genotypes; (C) UGT2B7 genotypes.
Fig. 3 | Scientific Reports
Blood primaquine levels among subjects with normal and reduced CYP2D6 activity phenotype, reference and alternate MAOA and UGT2B7 genotypes. (A) CYP2D6 phenotypes; (B) MAOA genotypes; (C) UGT2B7 genotypes.
